After more than fifteen years working across strategy, technology, medical training, and clinic development, the founder of KIOO Medical & Beauty Center in Mexico City understands a side of aesthetic medicine that rarely takes center stage: the structure behind an industry in constant growth.

Aesthetic medicine is also an industry. Behind every consultation, new technology, or treatment lies an infrastructure the patient rarely sees: companies, suppliers, training, purchasing decisions, business models, and commercial objectives. The outcome may ultimately be visible on the skin or face, but many of the decisions that made it possible were set in motion long before.

It is precisely within this territory that Yolnicte Bassave has built her career. With a background in business administration and management and more than fifteen years of experience in the medical aesthetics sector, her perspective has never been limited to what happens in front of the patient. It extends to the structure that allows a clinic to function: technology, medical training, strategy, and decision-making. Before founding KIOO Medical & Beauty Center, she worked training physicians and advising clinics, an experience that gave her a close view of both the possibilities of the industry and some of its contradictions.

Because innovation and growth do not always move at the same pace as knowledge and responsibility. Bassave speaks of professionals navigating technologies that do not necessarily deliver on their promises, patients whose expectations can be difficult to sustain, and suppliers capable of shaping even physicians’ expectations. For her, some of the problems within aesthetic medicine do not necessarily begin with the procedure itself. They can begin much earlier, within the commercial structure behind it.

Her position, however, is not a rejection of the business of aesthetics. It is a question of how that business is built. What happens when an industry grows faster than the judgment required to sustain it? Where does innovation end and excess begin? Can a clinic say no to a treatment and still be a successful business?

In conversation with Topics That Transform, Yolnicte Bassave considers aesthetic medicine from a perspective we hear far less often: not simply through the lens of what can be done, but through the business responsibility that comes with deciding whether it should be done.

A Clinic Begins Long Before the Consultation Room

TTT: Your background is in business administration and strategy, yet your career ultimately developed within aesthetic medicine. Did you understand the field as a business from the beginning?

Yolnicte Bassave: Always. I never saw aesthetic medicine simply as the business of treating a patient. I saw it as an enterprise, and for any business to succeed, responsibility has to exist at every level.

That responsibility begins with what you choose to offer, but it also extends to the people you choose to bring into the team. To me, building a responsible business means ensuring that every area meets the standards of excellence necessary to deliver an excellent service.

TTT: When you decided to create KIOO Medical & Beauty Center, what did you feel was still missing from the market?

YB: I saw excellent physicians and very good clinics, but I rarely found every element brought together in one place.

In some cases, technology was missing; in others, it was service, results, innovation in protocols, or physicians trained in newer techniques. Many of those elements existed independently, but I did not see a clinic that was integrating all of them successfully.

What Growth Can Also Leave Out of Sight

TTT: After more than a decade observing how this industry operates, what becomes visible once you also understand the business behind each treatment?

YB: You realize that not everything is as impeccable as it may appear from the outside.

One of the more uncomfortable realities is that some practices can cross into medical negligence, while certain promises of results are not always supported by the practitioner’s actual training or by the technology being used.

I have seen significant gaps in training and clinical practice that can result in patients being poorly treated or developing unrealistic expectations. I have also seen extraordinary results promised through devices that are not necessarily at the forefront of technology.

Even physicians themselves can become victims of expectations created by suppliers who promise results that, in practice, cannot always be delivered.

TTT: That creates an inevitable tension. Aesthetic medicine needs innovation, but it is also an industry that needs to grow and sell. Where do you draw the line between evolution and excess?

YB: Evolution happens when innovation is supported by science, continuing education, and medical ethics.

Excess begins when growth is driven more by the market than by the patient’s health. When the objective becomes selling without responsibility or increasing sales by creating products without sufficient medical support, that is where, for me, the line begins to be crossed.

When Knowledge Becomes Structure

TTT: You have dedicated an important part of your career to training physicians. Why is knowledge also part of a company’s ethical responsibility?

YB: Ethics have always been fundamental to me. Not just now, and not only within this industry. Ethical responsibility encompasses knowledge, study, and awareness. You cannot separate preparation from the responsibility you assume when that knowledge is put into practice.

TTT: When you advise on the opening of a clinic, how do you distinguish between someone who wants to build a company and someone who has simply identified a business opportunity?

YB: The first thing I look at is the physician’s vision: where they want to take the project and what kind of practice they want to build. When the motivation comes solely from thinking, “someone else is doing well,” it is generally more of a commercial opportunity than a genuine vision.

Many clinics emerge as copies of successful models, based on the assumption that replicating the formula will guarantee the same results. But in aesthetic medicine, authenticity carries more weight than imitation. Copying may generate revenue in the short term, but it rarely builds identity or a strong position in the market.

Thinking Beyond the Immediate Result

TTT: In an industry where immediate results can also become a sales tool, how do you build a practice capable of thinking long term?

YB: You have to shift the focus: stop pursuing immediate results alone and begin building sustainable processes.

Diagnosis should come before procedure. Listen more than you sell. Understand the patient’s anatomy, aging process, and history before intervening.

It also means prioritizing continuing education and medical judgment over viral trends. Not everything that is fashionable is appropriate for every face.

Another essential part is educating the patient. A responsible approach to aesthetics does not necessarily seek a dramatic transformation in a single session, but rather progressive, harmonious, and safe improvements over time. When patients understand that the objective can be preservation rather than exaggeration, their relationship with treatment changes as well.

And finally, there is commercial ethics: do not promise what you cannot sustain, and do not intervene when intervention is unnecessary. Knowing when to say no also builds reputation.

TTT: We talk extensively about which procedure to choose, but perhaps less about the decision that comes before the procedure. What should someone ask themselves before altering their body?

YB: They should understand that this is not simply about improving an image. You are intervening in a body that has a history, a structure, and biological limits. Every body is different, and it is equally important to understand what can be done and what cannot.

Before undergoing a procedure, someone should ask where that decision is coming from: Is it a conscious desire or an external pressure? Are they seeking harmony or pursuing an impossible standard?

Understanding the motivation is as important as understanding the procedure itself. For me, it is also about choosing to relate to our bodies more consciously and being able to look at ourselves in the mirror with love, whatever decision we ultimately make.

The Future Is Not About Correcting More

TTT: If you could define the future of aesthetic medicine in a single idea, what would it be?

YB: Less correction, more preservation.

The future should not be centered on transforming faces until they become unrecognizable, but on accompanying the natural aging process with intelligence, science, and respect for individuality. The direction is already moving toward treatments that are more preventive, less invasive, and increasingly personalized. True innovation will not necessarily lie in producing more visible changes, but in achieving results that are imperceptible, harmonious, and sustainable over time.

An aesthetic medicine that does not erase identity, but protects it.

If the industry evolves toward ethics, rigorous training, and conscious preservation, it can move away from selling perfection and begin offering well-being. And that, to me, is where the real future lies.